U.S.Food and Drug Administration
U.S.Food and Drug Administration, USA
Cheng Wang, M.D., Ph.D. is a Senior Scientist at the National Center for Toxicological Research (NCTR)/US Food and Drug Administration (FDA). He is also an Adjunct Faculty member in the Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences (UAMS). He is currently the P.I. on 4 research protocols supported by the NCTR/FDA, National Toxicology Program and NICHD. He is currently responsible for leading a research team that provides unique and highly specialized skills in toxicology, pharmacology, stem cell biology and systems biology research. He has published about 60 peer-reviewed research articles in prestigious journals and 10 book chapters. He is an Editor-in-Chief of the book entitled “Developmental Neurotoxicology Research: Principles, Models, Techniques, Strategies, and Mechanisms.” He also serves on the editorial board of 3 reputed journals and as a reviewer of 10 other journals. He was awarded the Outstanding Performance Award at the Society of Toxicology 44th Annual Meeting and the 2007 FDA Scientific Achievement Award for Excellence in Laboratory Science. He also was awarded a 2008 FDA Group Recognition Award for his participation in the Pediatric Anesthesia Research Group.
To minimize the risks to children resulting from the use of anesthesia; by using in vitro, in vivo, stem cell-derived models and preclinical research approaches (including molecular imaging, pharmacogeneomic/system biology approaches) to assess the neurotoxicity and to allow for the confirmation of toxicological outcome and biological pathways of anesthetic-induced cell death in the developing nonhuman primates and rodents.